Clinical Research Directory
Browse clinical research sites, groups, and studies.
BAROSTIM THERAPY™ In Resistant Hypertension
Sponsor: CVRx, Inc.
Summary
The purpose of this registry (NCT02880631) is to evaluate the effect of BAROSTIM THERAPY with the BAROSTIM NEO System in the commercial setting in subjects recently implanted under the CE-Marked indication for resistant hypertension.
Official title: BAROSTIM THERAPY™ In Resistant Hypertension: A Post-Market Registry With the CE-Marked BAROSTIM NEO™ System
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2016-12-13
Completion Date
2027-07
Last Updated
2026-09-11
Healthy Volunteers
No
Conditions
Interventions
BAROSTIM NEO™ System
Locations (26)
Charité Benjamin Franklin
Berlin, Germany
Charité Campus Virchow
Berlin, Germany
Immanuel Klinikum Bernau Herzzentrum Brandenburg
Bernau, Germany
Cloppenburg Katholische Kliniken Münsterland
Cloppenburg, Germany
Universitätsklinikum Köln Herzzentrum
Cologne, Germany
Lippe Klinikum
Detmold, Germany
Herzzentrum Dresden
Dresden, Germany
Krankenhaus Erding
Erding, Germany
Cardiovascular Center 'CVC' Frankfurt
Frankfurt, Germany
Universitätsklinikum Gießen und Marburg
Giessen, Germany
Herzzentrum Göttingen
Göttingen, Germany
Asklepios Klinik Altona
Hamburg, Germany
St. Barbara Klinik Hamm
Hamm, Germany
Kardiologie im Klinikum Ingolstadt
Ingolstadt, Germany
Universitätsklinikum Schleswig-Holstein Campus Kiel
Kiel, Germany
Herzentrum Lahr
Lahr, Germany
Universitätsklinikum Leipzig
Leipzig, Germany
Universitätsklinik Mainz
Mainz, Germany
Papenburg Marien Krankenhaus
Papenburg, Germany
Universitätsklinikum Regensburg
Regensburg, Germany
Marienkrankenhaus Siegen
Siegen, Germany
Krankenhaus & MVZ Maria-Hilf Stadtlohn GmbH
Stadtlohn, Germany
Klinikum Stuttgart
Stuttgart, Germany
Klinikum Tuttlingen
Tuttlingen, Germany
Heinrich-Braun Klinikum
Zwickau, Germany
Maastricht University Medical Center
Maastricht, Netherlands